Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian P Reiter

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|January 11, 2025
TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinomaFlorian P Reiter, Andreas Geier
Clinical and Translational Gastroenterology|September 21, 2020
Response to Chen et alLiangtao Ye, Florian P Reiter, Markus Guba, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 28, 2012
Hepatitis surface antigen clearance in a woman with liver cirrhosis and concomitant autoimmune hepatitis under immunosuppressive therapyFlorian P Reiter, Gerald U Denk, Norbert H Grüner, et al.
JHEP Reports : Innovation in Hepatology|August 6, 2024
Response to: "Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC"Najib Ben Khaled, Julia Mayerle, Enrico N De Toni, et al.
Clinical Nuclear Medicine|February 23, 2024
Monitoring Dual-Cancer Treatment in a Patient With Prostate and Hepatocellular Carcinoma Using Prostate-Specific Membrane Antigen-Directed PET/CTFlorian P Reiter, Alexander Weich, Takahiro Higuchi, et al.
The American Journal of Gastroenterology|August 28, 2020
Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation TreatmentLiangtao Ye, Changhua Zhang, Max Seidensticker, et al.
Cell Death Discovery|April 10, 2019
The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinomaLiangtao Ye, Julia Mayerle, Andreas Ziesch, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 11, 2021
Extending the Use of Atezolizumab and Bevacizumab to a Liver Transplant Recipient: Need for a Posttransplant RegistryNajib Ben Khaled, Daniel Roessler, Florian P Reiter, et al.
Nutrients|September 28, 2023
Salt-Intake-Related Behavior Varies between Sexes and Is Strongly Associated with Daily Salt Consumption in Obese Patients at High Risk for MASLDBianca Heller, Florian P Reiter, Hans Benno Leicht, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutationsFlorian P Reiter, Monika Rau, Volker Kunzmann, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|January 11, 2025
TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinomaFlorian P Reiter, Andreas Geier
Clinical and Translational Gastroenterology|September 21, 2020
Response to Chen et alLiangtao Ye, Florian P Reiter, Markus Guba, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 28, 2012
Hepatitis surface antigen clearance in a woman with liver cirrhosis and concomitant autoimmune hepatitis under immunosuppressive therapyFlorian P Reiter, Gerald U Denk, Norbert H Grüner, et al.
JHEP Reports : Innovation in Hepatology|August 6, 2024
Response to: "Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC"Najib Ben Khaled, Julia Mayerle, Enrico N De Toni, et al.
Clinical Nuclear Medicine|February 23, 2024
Monitoring Dual-Cancer Treatment in a Patient With Prostate and Hepatocellular Carcinoma Using Prostate-Specific Membrane Antigen-Directed PET/CTFlorian P Reiter, Alexander Weich, Takahiro Higuchi, et al.
The American Journal of Gastroenterology|August 28, 2020
Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation TreatmentLiangtao Ye, Changhua Zhang, Max Seidensticker, et al.
Cell Death Discovery|April 10, 2019
The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinomaLiangtao Ye, Julia Mayerle, Andreas Ziesch, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 11, 2021
Extending the Use of Atezolizumab and Bevacizumab to a Liver Transplant Recipient: Need for a Posttransplant RegistryNajib Ben Khaled, Daniel Roessler, Florian P Reiter, et al.
Nutrients|September 28, 2023
Salt-Intake-Related Behavior Varies between Sexes and Is Strongly Associated with Daily Salt Consumption in Obese Patients at High Risk for MASLDBianca Heller, Florian P Reiter, Hans Benno Leicht, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutationsFlorian P Reiter, Monika Rau, Volker Kunzmann, et al.
Pageof 6